Disciplina Capital Management LLC Catalent, Inc. Transaction History

Disciplina Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 16, 2023	SELL	$87.2 - $114.05 $30,520 - $39,917	-350 Closed	0 $0
Q1 2022 Nov 16, 2023	SELL	$94.19 - $124.49 $753 - $995	-8 Reduced 2.23%	350 $38.8 Million
Q4 2021 Nov 16, 2023	BUY	$119.57 - $139.07 $40,175 - $46,727	336 New	336 $43 Million
Q3 2021 Nov 16, 2023	BUY	$109.17 - $142.35 $1,419 - $1,850	13 Added 3.77%	358 $47.6 Million
Q2 2021 Nov 16, 2023	BUY	$100.34 - $115.69 $5,217 - $6,015	52 Added 17.75%	345 $37.3 Million
Q1 2021 Nov 16, 2023	BUY	$101.51 - $125.27 $10,760 - $13,278	106 Added 56.68%	293 $30.9 Million
Q4 2020 Nov 16, 2023	BUY	$85.88 - $105.36 $16,059 - $19,702	187 New	187 $19.5 Million

490

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Disciplina Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplina Capital Management LLC with notifications on news.